Richard Nolan Townsend, Chief Executive Officer at Lexeo Therapeutics, Inc. (LXEO), sold 55,000 shares at $5.69 ($313K) on 2026-04-06, disclosed to the SEC on 2026-04-07.
Scheduled sale ($313k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| LXEO | SELL | 2026-05-20 | $17K | — | Filing → |
| LXEO | SELL | 2026-02-20 | $65K | — | Filing → |
| LXEO | SELL | 2025-11-20 | $10K | — | Filing → |